Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Medico Kemiske Holding ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0%   Bankruptcy risk   1.5% 1.2% 1.1% 1.9% 1.2% 2.2% 8.1% 8.1%   Credit score (0-100)   78 83 84 69 83 65 30 30   Credit rating   A A A A A BBB BB BB   Credit limit (kDKK)   52.7 363.8 885.3 5.0 468.0 0.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -730 -601 1,010 -444 -279 -68.0 0.0 0.0   EBITDA   -2,638 -2,002 515 -444 -379 -268 0.0 0.0   EBIT   -2,638 -2,002 515 -444 -379 -268 0.0 0.0   Pre-tax profit (PTP)   1,506.9 3,671.3 16,638.0 -61.9 422.9 -192.0 0.0 0.0   Net earnings   2,705.3 4,270.7 16,492.0 -60.0 444.4 -208.4 0.0 0.0   Pre-tax profit without non-rec. items   1,507 3,671 16,638 -61.9 423 -192 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   5,112 1,754 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   16,073 18,344 22,034 17,974 16,219 14,030 10,631 10,631   Interest-bearing liabilities   11,219 6,613 1,868 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   29,051 26,226 24,879 18,847 16,403 14,109 10,631 10,631   Net Debt   11,011 5,079 -1,035 -376 -41.3 -121 -10,631 -10,631     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -730 -601 1,010 -444 -279 -68.0 0.0 0.0   Gross profit growth   28.7% 17.7% 0.0% 0.0% 37.1% 75.6% 0.0% 0.0%   Employees   3 3 1 0 1 1 0 0   Employee growth %   0.0% 0.0% -66.7% -100.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   29,051 26,226 24,879 18,847 16,403 14,109 10,631 10,631   Balance sheet change%   9.1% -9.7% -5.1% -24.2% -13.0% -14.0% -24.7% 0.0%   Added value   -2,638.1 -2,001.6 514.8 -443.8 -379.4 -268.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 -3,358 -1,754 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   361.2% 332.8% 51.0% 100.0% 135.8% 393.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.6% 18.4% 65.3% -0.3% 2.4% -1.2% 0.0% 0.0%   ROI %   6.1% 14.3% 68.3% -0.3% 2.5% -1.2% 0.0% 0.0%   ROE %   17.8% 24.8% 81.7% -0.3% 2.6% -1.4% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   55.3% 69.9% 88.6% 95.4% 98.9% 99.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -417.4% -253.8% -201.0% 84.8% 10.9% 45.2% 0.0% 0.0%   Gearing %   69.8% 36.0% 8.5% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.5% 0.8% 0.8% 0.7% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.5 1.2 3.5 73.2 18.7 40.9 0.0 0.0   Current Ratio   0.5 1.2 3.5 73.2 18.7 40.9 0.0 0.0   Cash and cash equivalent   207.4 1,533.2 2,902.5 376.3 41.3 121.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -4,710.0 1,456.6 4,791.9 4,523.4 3,269.1 3,145.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -879 -667 515 0 -379 -268 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -879 -667 515 0 -379 -268 0 0   EBIT / employee   -879 -667 515 0 -379 -268 0 0   Net earnings / employee   902 1,424 16,492 0 444 -208 0 0